Schwabe

Dr. Willmar Schwabe is a fifth-generation, family-owned pharmaceutical company with more than 160 years of experience in plant-based medicine. The company researches, develops, manufactures and packages its medicines in Germany, managing the process from cultivation through to the finished product. Its work combines knowledge of traditional herbal remedies with scientific research and the quality, safety and efficacy requirements applied to other medicines. Schwabe reports investing around €35 million annually in research and development, supported by a team of more than 100 people in that field.

The brand offers phytopharmaceuticals and health information across areas including respiratory health, digestion, heart and circulation, sleep, stress, mood, dizziness, memory, skin care, wound healing and muscle and joint discomfort. Its product range includes Carmenthin, Crataegutt, Dermaplant, Doloplant, Hametum, Lasea, Neuroplant, Pinimenthol, Prostagutt, Refluthin, Tebonin, Umckaloabo, Venoplant and Vitango. Schwabe also provides consumer guides, brochures and resources about herbal medicines and phytotherapy, alongside information for healthcare professionals. Sustainability and environmental protection are part of the company’s stated priorities.